PMID: 8612046Jan 1, 1995Paper

Antiviral effect of phosphorothioate oligodeoxyribonucleotides complementary to human immunodeficiency virus

Bioorganic & Medicinal Chemistry
S G KimH Takaku

Abstract

Modifications of oligodeoxyribonucleotides include the replacement of the backbone phosphodiester groups with phosphorothioate (S-ODNs) groups and the substitution of phosphorothioate (SO-ODNs) groups at both the 3'- and 5'-ends. In assays for HIV, oligomers (S-ODNs) were more active at the micromolar range than were SO-ODNs of the same sequence. Furthermore, the abilities of antisense-, sense-, random-, and mismatched-oligomers, or homo-oligomers containing internucleotidic phosphorothioate linkages to inhibit HIV-1 replication were examined. Antisense oligonucleotides inhibit the replication and the expression of HIV-1 more efficiently than random-, sense-, mismatched-, and homo-oligomers of the same length or with the same internucleotide modification. Five different target sites (gag, pol, rev, tat, and tar) within the HIV genes were also studied with regard to the inhibition of HIV replication by antisense oligonucleotides. Antisense oligomers complementary to the sites of initiation sequences and to certain splice sites were most effective. The effect of antisense oligomer length on inhibiting viral replication was also investigated. Of particular interest was the S-ODNs-rev 15 mer, which possessed higher anti-HIV activit...Continue Reading

References

Jan 1, 1978·Proceedings of the National Academy of Sciences of the United States of America·P C Zamecnik, M L Stephenson
Aug 1, 1988·Journal of Virological Methods·R PauwelsE De Clercq
Jan 24, 1985·Nature·L RatnerK Baumeister
Jan 1, 1985·Cell·S Wain-HobsonM Alizon
Apr 1, 1986·Proceedings of the National Academy of Sciences of the United States of America·S K Arya, R C Gallo
Jun 1, 1986·Proceedings of the National Academy of Sciences of the United States of America·P C ZamecnikP S Sarin
Feb 1, 1987·Proceedings of the National Academy of Sciences of the United States of America·M LemaitreB Lebleu
Oct 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·S AgrawalP C Zamecnik
Feb 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·E L WickstromE Wickstrom
Nov 1, 1987·Proceedings of the National Academy of Sciences of the United States of America·M MatsukuraS Broder
Apr 1, 1980·Canadian Journal of Biochemistry·R Greene, B Munson
Feb 1, 1993·Proceedings of the National Academy of Sciences of the United States of America·A M KriegC A Stein
May 1, 1993·Proceedings of the National Academy of Sciences of the United States of America·J LisziewiczS Agrawal

❮ Previous
Next ❯

Citations

Sep 27, 2002·Antiviral Research·Neerja KaushikVirendra N Pandey
Apr 9, 2001·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·T AbeH Takaku
Jan 1, 2008·Gene Regulation and Systems Biology·Moizza Mansoor, Alirio J Melendez

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antisense Oligonucleotides: ND

This feed focuses on antisense oligonucleotide therapies such as Inotersen, Nusinursen, and Patisiran, in neurodegenerative diseases including amyotrophic lateral sclerosis.

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.